Phase I drug-drug interaction study of Veltassa (patiromer) with Amlodipine in healthy volunteers

Trial Profile

Phase I drug-drug interaction study of Veltassa (patiromer) with Amlodipine in healthy volunteers

Recruiting
Phase of Trial: Phase I

Latest Information Update: 13 Feb 2017

At a glance

  • Drugs Patiromer (Primary) ; Amlodipine
  • Indications Hyperkalaemia
  • Focus Adverse reactions
  • Sponsors Relypsa
  • Most Recent Events

    • 13 Feb 2017 According to a Relypsa media release, results from this study were published in the Journal of Cardiovascular Pharmacology and Therapeutics.
    • 25 May 2016 According to a company media release, Relypsa submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) requesting label changes for Veltassa (patiromer) for oral suspension based on results of this and other Phase 1 drug-drug interaction studies in healthy volunteers.
    • 29 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top